Spinraza - FDA prescribing information, side effects and uses
Roche's low-price Evrysdi will take 'meaningful' SMA share from Biogen's Spinraza: analyst | FiercePharma
5. Spinraza | FiercePharma
Buy Spinraza (Nusinersen) Online • Price & Costs | TheSocialMedwork
NHS to use world's most expensive drug to treat spinal muscular atrophy | NHS | The Guardian
Official HCP Homepage | SPINRAZA® (nusinersen) | HCP
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Novartis' £1.79M gene therapy Zolgensma scores cost watchdog's backing, threatening Biogen's Spinraza | FiercePharma
HSE to consider funding Spinraza as NHS approves muscle-wasting therapy
Biogen update on European access to Spinraza – TreatSMA
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Biogen bounces back with Spinraza early treatment data - PMLiVE
Farmalisa - Spinraza is a medicine used to treat 5q spinal muscular atrophy (SMA), a genetic disease that causes weakness and wasting of the muscles including the lung muscles. The disease is
NHS to use world's most expensive drug to treat spinal muscular atrophy | NHS | The Guardian
A potential side effect added to Spinraza label – TreatSMA
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study - The Lancet
Spinraza (PF) intrathecal: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
Safety | SPINRAZA® (nusinersen) HCP
NHS labels Spinraza deal “one of the most comprehensive in the world”
